Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A2 | P43354 | 3/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 11/20 | 0.65 |
| ▸ | MEN1 | O00255 | 3/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | THRB | P10828 | 1/20 | 0.60 |
| ▸ | GAA | P10253 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22955702 | 0.85 | MAPT (0.50) | NR4A2KMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL3050804 | 0.83 | NR4A2 (0.47) | NR4A2KMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL19691124 | 0.83 | NR4A2 (0.47) | NR4A2KMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL31621504 | 0.81 | NR4A2 (1.00) | NR4A2KMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL1092934 | 0.81 | NR4A2 (1.00) | NR4A2KMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL5543207 | 0.80 | NR4A2 (0.69) | NR4A2KMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL13936213 | 0.80 | NR4A2 (0.69) | NR4A2KMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL27873322 | 0.80 | NR4A2 (0.69) | NR4A2KMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL15558170 | 0.80 | NR4A2 (0.69) | NR4A2KMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL11218801 | 0.79 | NR4A2 (0.50) | NR4A2KMT2AMEN1KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2323485-B1 | ANTI-ALLERGEN COMBINATIONS OF CALCIUM AND LANTHANUM SALTS | JANSSEN PHARMACEUTICA NV (BE) | 2013-10-16 | — | — | EP | disclosed |
| US-20110196006-A1 | IMAZALIL COMPOSITIONS COMPRISING ALKOXYLATED AMINES | BYLEMANS DANY LEOPOLD JOZEFIEN | 2011-08-11 | — | — | US | disclosed |
| US-20110135750-A1 | ANTI-ALLERGEN COMBINATIONS OF CALCIUM AND LANTHANUM | BYLEMANS DANY LEOPOLD JOZEFIEN | 2011-06-09 | — | — | US | disclosed |
| EP-2323485-A1 | ANTI-ALLERGEN COMBINATIONS OF CALCIUM AND LANTHANUM SALTS | Janssen Pharmaceutica, N.V. (BE) | 2011-05-25 | — | — | EP | disclosed |
| WO-2010015697-A1 | ANTI-ALLERGEN COMBINATIONS OF CALCIUM AND LANTHANUM SALTS | JANSSEN PHARMACEUTICA NV (BE) | 2010-02-11 | — | — | WO | disclosed |
| US-20090093505-A1 | Imazalil compositions comprising alkoxylated amines | JANSSEN PHARMACEUTICA N.V. (BE) | 2009-04-09 | — | — | US | disclosed |
| US-20090028796-A1 | PESTICIDAL COMPOSITION COMPRISING INDOLE DERIVATES | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V. (DE) | 2009-01-29 | — | — | US | disclosed |
| EP-1784076-A1 | IMAZALIL COMPOSITIONS COMPRISING ALKOXYLATED AMINES | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-05-16 | — | — | EP | disclosed |
| WO-2006021556-A1 | IMAZALIL COMPOSITIONS COMPRISING ALKOXYLATED AMINES | JANSSEN PHARMACEUTICA N.V. (BE) | 2006-03-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090093505-A1 | Imazalil compositions comprising alkoxylated amines | INMT, TYR, TH | NR4A2 4684/4885KMT2A 478/4885MEN1 1588/4885 |
| US-20110196006-A1 | IMAZALIL COMPOSITIONS COMPRISING ALKOXYLATED AMINES | INMT, TYR, TH | NR4A2 4684/4885KMT2A 478/4885MEN1 1588/4885 |
| US-20090028796-A1 | PESTICIDAL COMPOSITION COMPRISING INDOLE DERIVATES | IDO1, IDO2, INMT | NR4A2 4675/4885KMT2A 3257/4885MEN1 3306/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.